SIRT Clinical Trials
5 recruitingProcedure
Not Applicable2Phase 11Phase 21
Showing 1–5 of 5 trials
Recruiting
Phase 1
SIRT With Tremelimumab and Durvalumab for Resectable HCC
Hepatocellular CarcinomaHepatocellular CancerResectable Hepatocellular Carcinoma
Jiping Wang, MD, PhD20 enrolled3 locationsNCT05701488
Recruiting
Not Applicable
SIRT Versus cTACE for Unresectable HCC (CHANCE2506)
Unresectable Hepatocellular Carcinoma
Zhongda Hospital108 enrolled1 locationNCT06909708
Recruiting
Phase 2
Y-90 SIRT for Unresectable HCC Larger Than 7cm
Second Affiliated Hospital of Guangzhou Medical University33 enrolled2 locationsNCT06707233
Recruiting
Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
Unresectable Hepatocellular Carcinoma (HCC)Liver Metastases From Colorectal Cancer (mCRC)
Sirtex Medical845 enrolled9 locationsNCT05967143
Recruiting
Not Applicable
SIRT for Potentially Resectable HCC
Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University35 enrolled1 locationNCT05994859